CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

Select one or more of the filter options below

CLOSE

Executing FDA Pre-Approval Material Review

AUTHOR: CMK SELECT

A pharmaceutical company with a lead compound in review to the FDA was  in the process of developing promotional and medical assets to support the product. The approval process required medical, legal, and regulatory review of all submitted…
CONTINUE READING

Developing and Executing a Medical Strategy

AUTHOR: CMK SELECT

A small biopharmaceutical company is building a Medical Affairs organization and sought to understand the medical landscape and unmet medical need to create medical strategy and build an integrated medical and brand plan for a lead compound. The…
CONTINUE READING

Successfully Transitioning From Field Force to Digital Marketing

AUTHOR: CMK SELECT

A brand team had to develop a marketing plan leading up to a product’s loss of exclusivity. Most of the brand team and field force were disbanded and the marketing budget for the brand was significantly decreased. How…
CONTINUE READING

Efficiently Executing Safety Label Updates

AUTHOR: CMK SELECT

A well-known pharmaceutical drug with six indications, received multiple safety label updates within one year. The changes to the label impacted the Important Safety Information, which in turn required updating of each indication’s marketing materials (print and digital).…
CONTINUE READING

DRUG SAFETY-RELATED LABELING CHANGES (SrLC) – PART II

AUTHOR: CMK SELECT

BENEFITS OF CENTRALIZING THE LABEL UPDATE PROCESS ACROSS AN ORGANIZATION Pharmaceutical marketing departments that centralize and standardize their approach to required label/Important Safety Information (ISI) updates, including the advance planning of upcoming labeling changes and continued optimization of their internal…
CONTINUE READING

DRUG SAFETY-RELATED LABELING CHANGES (SrLC) – PART I

AUTHOR: CMK SELECT

EFFICENTLY MANAGING REVISIONS TO MARKETING MATERIALS At any time during the active marketing of a pharmaceutical product, there is a high probability of having to implement a safety label update, impacting the Important Safety Information (ISI) that is highlighted in…
CONTINUE READING

CMK Select Supports Pharmaceutical Leader in Delivering Next-gen Data & Digital Strategy by Driving Successful Change Management

AUTHOR: CMK SELECT

When the U.S. Oncology team of a global pharmaceutical company were ready to execute on the vision of industry-leading engagement, they looked to CMK to help them translate it with structured change management. Healthcare providers were receiving massive…
CONTINUE READING

CMK Select Works With Life Sciences Data Analytics Team to Explore Key Project Management Knowledge Areas

AUTHOR: CMK SELECT

A Client’s Life Sciences data analytics team was seeking to gain foundational knowledge of project management.  The team’s existing work environment centered around rapid response to their internal clients. The result was frequent scope creep, dissatisfied clients, and…
CONTINUE READING

CMK Brings Order to Pharma Company’s Struggling Multi-Product, Multi-Release Launch

AUTHOR: CMK SELECT

A privately owned, rapidly growing pharmaceutical company was charged with rolling out 22 releases for a multi-product launch in one year’s time. In the early stages of the program, the client struggled with a series of issues that,…
CONTINUE READING

CMK Helps Global Pharmaceutical Leader Streamline Processes and Protocols to Meet Government Requirements and Deliver Ongoing Operational Efficiencies

AUTHOR: CMK SELECT

The U.S. cardiovascular team of a global pharmaceutical company needed help responding to a new Corporate Integrity Agreement for two launch products. Resource-constrained at the time, they were looking for a streamlined and efficient way to satisfy the…
CONTINUE READING

Pharma Giant Sees Six-Fold Boost in Awareness of New Myeloid Disease Treatment With CMK Select

AUTHOR: CMK SELECT

Within hematology, Higher Risk-Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia (AML) are diseases with a highly unmet treatment need. In response, an NJ-based pharmaceutical leader created an innovative new immune-modulating treatment that shows tremendous promise in the fight…
CONTINUE READING

CMK Helps Pharmaceutical Leader Streamline and Integrate Processes and Procedures for Study Teams Following Merger

AUTHOR: CMK SELECT

When two large pharmaceutical companies merged, the study teams struggled with a lack of clarity over which operating models to follow for their respective studies. With heritage procedures and IT systems in place across both entities, and pros…
CONTINUE READING

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP